Processa Pharmaceuticals, Inc. (PCSA)
$1.52+12.59%Close
SELLCRISIS · day 39
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $3M
- Beta
- 0.97
- P/E (TTM)
- -0.27
- Short % float
- 0.20%
- Days to cover
- 1.0
- SI change
- -72.4%
- 1W
- -5.59%
- 1M
- -17.84%
- vs SPY 1W
- -6.75%
- vs SPY 1M
- -20.83%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on PCSA?
- LOPJLB’s latest quantitative signal on Processa Pharmaceuticals, Inc. (PCSA) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is PCSA in?
- Processa Pharmaceuticals, Inc. (PCSA) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Processa Pharmaceuticals, Inc. (PCSA) do?
- Processa Pharmaceuticals, Inc. is a biopharmaceutical company in the clinical development stage, committed to identifying and progressing therapeutic agents for patients with critical unmet medical requirements throughout the United States. The company's leading investigational drug, PCS499, is an oral tablet presently undergoing Phase 2B clinical assessment. It aims to treat both ulcerative an…